SCHEMBL5200748

SCHEMBL5200748

O=C(O)Oc1cc2cccc(Br)c2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA1 P02708 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA4 P43681 1/20 0.39
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC10 Q969S8 2/20 0.36
HDAC11 Q96DB2 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC9 Q9UKV0 2/20 0.36
HDAC5 Q9UQL6 2/20 0.36
CA2 P00918 2/20 0.36
MAPT P10636 2/20 0.34
CYP1A2 P05177 1/20 0.34
GAA P10253 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200826 0.84 CHRNA1 (0.40) CHRNA1CHRNB2CHRNB4CHRNA4HDAC3
SCHEMBL5229909 0.80 HDAC3 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5234936 0.80 CA2 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5233818 0.80 CHRNA7 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5236819 0.76 CHRNA7 (0.41) CA2MAPTGAAKDM4EALDH1A1
SCHEMBL5233353 0.76 HDAC3 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1091530 0.76 BCL2L1 (0.53) CHRNA1CHRNB2CHRNB4CHRNA4HDAC3
SCHEMBL5202302 0.75 SLC9A1 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5232375 0.75 MEN1 (0.44) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL1091054 0.74 HPGD (0.54) CHRNA1CHRNB2CHRNB4CHRNA4HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1527073-B1 BENZOTHIOPHENE UREA, BENZOFURANE UREA, AND INDOLE UREA, AND USE OF THE SAME AS ALPHA-7 ACHR AGONISTS BAYER HEALTHCARE AG (DE) 2007-08-22 EP disclosed
EP-1461335-B1 2-HETEROARYLCARBOXYLIC ACID AMIDES BAYER HEALTHCARE AG (DE) 2007-02-28 EP disclosed
EP-1515967-B1 2-HETEROARYL CARBOXAMIDES BAYER HEALTHCARE AG (DE) 2006-11-02 EP disclosed
EP-1458716-B1 BICYCLIC N-ARYLAMIDES BAYER HEALTHCARE AG (DE) 2006-09-27 EP disclosed
EP-1527073-A1 BENZOTHIOPHENE UREA, BENZOFURANE UREA, AND INDOLE UREA, AND USE OF THE SAME AS ALPHA-7 ACHR AGONISTS Bayer HealthCare AG (DE) 2005-05-04 EP disclosed
EP-1515967-A1 2-HETEROARYL CARBOXAMIDES Bayer HealthCare AG (DE) 2005-03-23 EP disclosed
EP-1461335-A1 2-HETEROARYLCARBOXYLIC ACID AMIDES Bayer HealthCare AG (DE) 2004-09-29 EP disclosed
EP-1458716-A1 BICYCLIC N-ARYLAMIDES Bayer HealthCare AG (DE) 2004-09-22 EP disclosed
WO-2004013136-A1 BENZOTHIOPHENE UREA, BENZOFURANE UREA, AND INDOLE UREA, AND USE OF THE SAME AS ALPHA-7 ACHR AGONISTS BAYER HEALTHCARE AG (DE) 2004-02-12 WO disclosed
WO-2003104227-A1 2-HETEROARYL CARBOXAMIDES BAYER HEALTHCARE AG (DE) 2003-12-18 WO disclosed
WO-2003055878-A1 2-HETEROARYLCARBOXYLIC ACID AMIDES BAYER HEALTHCARE AG (DE) 2003-07-10 WO disclosed
WO-2003051874-A1 BICYCLIC N-ARYLAMIDES BAYER HEALTHCARE AG (DE) 2003-06-26 WO disclosed